| |
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
2026―Mai―11 |
Demystifying Drivers of SARS-CoV-2-Mediated Dysregulation of Drug Processing Genes (Abstract ID: 224439) |
Chukwunonso K. Nwabufo |
| 2 |
[GO] |
2026―Mai―11 |
Mechanistic Investigation of OJT003 Activity Against Wild-Type and Omicron SARS-CoV-2 Using Molecular Dynamics Simulations (Abstract ID: 274715) |
Brett Afiwa Tapoyo, Kehinde A. Idowu, Scott J. Widmann, Esther A. Olaleye |
| 3 |
[GO] |
2026―Mai―11 |
Plasma ACE and ACE2 Levels Are Altered in Patients With COVID-19 (Abstract ID: 222928) |
Murat Oz, Wassim Chehadeh, Omamah Alfarisi, Farhan Cyprian |
| 4 |
[GO] |
2025―Mrz―29 |
Kruppel-like Factor 2 (KLF2) Reduces Parameters of Coronavirus Disease-Related Pathogenesis (Abstract ID: 158457) |
MD Sariful Islam Howlader, Manjusri Das, Surajit Hansda, Prathyusha Naidu, Hiranmoy Das |
| 5 |
[GO] |
2025―Mrz―28 |
SARS-CoV-2 Propagation Relies on Host Chaperonin CCT/TRiC Folding of Viral Polymerase Nsp12 (Abstract ID: 171782) |
Cecilia S. Sanders, Theresa M. Smith, Caelen A. Jones, Gavin T. Scholl, Mikaila Sass, Peter Shen, Barry Willardson |
| 6 |
[GO] |
2025―Mrz―28 |
Targeting S1PR1 for Post-Acute Neurocognitive Sequalae of SARS-CoV-2 (Abstract ID: 163823) |
Susan Farr, Heather Macarathur, Ivonne G. Larrea, Timothy Doyle, Daniela Salvemini |
| 7 |
[GO] |
2024―Aug―23 |
KVX-053, a Protein Tyrosine Phosphatase 4A3 inhibitor, ameliorates SARS-CoV-2 Spike protein subunit 1 - induced acute lung injury in mice |
Pavel A Solopov, Ruben Manuel Luciano Colunga Biancatelli, Tierney Day, Betsy Gregory, Elizabeth R Sharlow, John S. Lazo, John D Catravas |
| 8 |
[GO] |
2024―Feb―09 |
Endothelial extracellular vesicles enriched in microRNA-34a predict new-onset diabetes in COVID-19 patients: novel insights for long-COVID metabolic sequelae |
Pasquale Mone, Stanislovas S. Jankauskas, Maria Virginia Manzi, Jessica Gambardella, Antonietta Coppola, Urna Kansakar, Raffaele Izzo, Giuseppe Fiorentino, Angela Lombardi, Fahimeh Varzideh, Daniela Sorriento, Bruno Trimarco, Gaetano Santulli |
| 9 |
[GO] |
2023―Mai―18 |
Finasteride Induces Epigenetic Alteration of TMPRss2 Gene Expression: A Potential role in Severe Acute Respiratory Syndrome-Corona Virus-2 Inhibition |
Churchill Ihentuge, Antonei B. Csoka |
| 10 |
[GO] |
2023―Mai―18 |
Molecular Dynamics Studies for Nirmatrelvir and the Main Protease from Variants of the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) |
Kathleen Frey, Ongshu Dutta, Lilian Tran, Brandon Yin, Andrew Makarus, Raymond Marmol, Youssef Dawood |
| 11 |
[GO] |
2023―Mai―18 |
Characterization of the pharmacological mechanism of OJT009 as a novel inhibitor of severe acute respiratory syndrome coronavirus 2 |
Tolulope Adebusuyi, Manvir Kaur, Anuoluwapo O. Egbejimi, Idowu Kehinde, Omonike A. Olaeye |
| 12 |
[GO] |
2023―Mai―18 |
Changes of ACE-2 related-miR-200b-3p expression over time are a predictive factor of long hospitalization for COVID-19: in silico, machine learning and validation analysis |
Disha Keswani, Mikolaj Marszalek, Zofia Wicik, Ceren Eyileten, Anna Nowak, Sérgio Simões, David Martins, Krzysztof Klos, Wojciech Wlodarczyk, Alice Assinger, Dariusz Soldacki, Andrzej Chcialowski, Jolanta Siller-Matula, Marek Postula |
| 13 |
[GO] |
2023―Mai―18 |
Pharmacovigilance of the COVID-19 Vaccine in Ecuador During the First and Second Doses of Vaccination Campaigns |
Andrea Orellana Manzano, Fernanda B. Cordeiro, Andrea Garcia-Angulo, Diana Carvajal-Aldaz, Elizabeth Centeno, Maria J. Vizcaíno, Sebastián Poveda, Ricardo Murillo, Derly Andrade-Molina, Saurabh Mehta, Washinton Cardenas |
| 14 |
[GO] |
2023―Mai―18 |
Development of Humanized ACE2 Mouse and Rat Models for COVID-19 Research |
Hongmei Jiang, Emma Hyddmark, Jianqiu Xiao, Sara Gordon, Angela Bartels, Yumei Wu, Joe Warren, Lauren Klaskala, Andrew Brown, Michael Garratt, Helmut Ehall, Guojun Zhao |
| 15 |
[GO] |
2023―Mai―18 |
Renin-Angiotensin System Components and Arachidonic Acid Metabolites as Biomarkers of COVID-19 |
Biwash Ghimire, Sana Khajehpour, Nasser Jalili Jahani, Elizabeth A. Middleton, Robert Campbell, Mary Nies, Ali Aghazadeh-Habashi |
| 16 |
[GO] |
2023―Apr―27 |
Modulation of the immune response to SARS-CoV-2 vaccination by NSAIDs |
Carsten Skarke, Ronan Lordan, Kayla Barekat, Amruta Naik, Divij Mathew, Takuya Ohtani, Allison R Greenplate, Gregory R Grant, Nicholas F Lahens, Sigrid Gouma, Elizabeth Troisi, Arjun Sengupta, Aalim M Weljie, Wenzhao Meng, Eline T Luning Prak, Kendall Lundgreen, Paul Bates, Hu Meng, Garret A. FitzGerald |
| 17 |
[GO] |
2022―Jul―03 |
Cardiovascular implications of miRNAs in COVID-19 |
Carmine Izzo, Valeria Visco, Jessica Gambardella, Germano Junior Ferruzzi, Antonella Rispoli, Maria Rosaria Rusciano, Anna Laura Toni, Nicola Virtuoso, Albino Carrizzo, Paola Di Pietro, Guido Iaccarino, Carmine Vecchione, Michele Ciccarelli |
| 18 |
[GO] |
2022―Jun―30 |
Exosomal miR-145 and miR-885 regulate thrombosis in COVID-19 |
Jessica Gambardella, Urna Kansakar, Celestino Sardu, Vincenzo Messina, Stanislovas S. Jankauskas, Raffaele Marfella, Paolo Maggi, Xujun Wang, Pasquale Mone, Giuseppe Paolisso, Daniela Sorriento, Gaetano Santulli |
| 19 |
[GO] |
2022―Mrz―26 |
L-Arginine Enhances the Effects of Cardiac Rehabilitation on Physical Performance: New Insights for Managing Cardiovascular Patients During the COVID-19 Pandemic |
Pasquale Mone, Raffaele Izzo, Giuseppe Marazzi, Maria Virginia Manzi, Paola Gallo, Giuseppe Campolongo, Luca Cacciotti, Domenico Tartaglia, Giuseppe Caminiti, Fahimeh Varzideh, Gaetano Santulli, Valentina Trimarco |
| 20 |
[GO] |
2021―Jul―12 |
Cationic Compounds with SARS-CoV-2 Antiviral Activity and their Interaction with OCT/MATE Secretory Transporters. |
Lucy Jazmin Martinez Guerrero, Xiaohong Zhang, Kimberley M. Zorn, Sean Ekins, Stephen H. Wright |
| 21 |
[GO] |
2021―Mai―10 |
Viral Proteases as Targets for COVID-19 Drug Development |
Wei Zhu, Zeenat A Shyr, Donald C. Lo, Wei Zheng |
| 22 |
[GO] |
2021―Mrz―05 |
COVID-19 drugs chloroquine and hydroxychloroquine, but not azithromycin and remdesivir, block hERG potassium channels |
Mark Szendrey, Jun Guo, Wentao Li, Tonghua Yang, Shetuan Zhang |
| 23 |
[GO] |
2020―Okt―28 |
A Biomarker-Centric Approach to Drug Discovery and Development: Lessons Learned from the COVID-19 Pandemic |
Kelly A. Fader, Jiangwei Zhang, Joseph P. Menetski, Ravi I. Thadhani, Elliott M. Antman, Gary S. Friedman, Shashi K. Ramaiah, Vishal S. Vaidya |
| 24 |
[GO] |
2020―Okt―08 |
The Role of Smoking and Nicotine in the Transmission and Pathogenesis of COVID-19 |
Ali Ehsan Sifat, Saeideh Nozohouri, Heidi Villalba, Bhuvaneshwar Vaidya, Thomas J. Abbruscato |
| 25 |
[GO] |
2020―Okt―02 |
Role of GILZ in the Kidney and the Cardiovascular System: Relevance to Cardiorenal Complications of COVID-19 |
Mahmood Mozaffari |
| 26 |
[GO] |
2020―Jul―29 |
Drug discovery strategies for SARS-CoV-2 |
Zeenat A Shyr, Kirill Gorshkov, Catherine Z Chen, Wei Zheng |
|
